Peter Rasmussen
Comptroller/Controller/Auditor chez ASCENDIS PHARMA A/S
Fortune : 59 107 $ au 31/03/2024
Provenance du réseau au premier degré de Peter Rasmussen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 | |
| Subsidiary | Pharmaceuticals: Major | 6 | |
AdvanDx, Inc.
 AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA.
4
| Extinct | Medical Specialties | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Rasmussen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Secretary Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Sales & Marketing Chairman | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| ALK-ABELLÓ A/S | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Aarhus | College/University | Graduate Degree | |
| Technical University of Denmark | College/University | Doctorate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Dako Corp.
 Dako Corp. Medical/Nursing ServicesHealth Services Dako Corp. manufactures and markets cell based cancer diagnostics for both clinical diagnostics and research use. It is engaged in innovative detection systems, instrumentation antibodies for bioresearch, immunohistochemistry and flow cytometry. The company is located in Carpinteria, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Undergraduate Degree Doctorate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chairman | |
Visiopharm A/S
 Visiopharm A/S Packaged SoftwareTechnology Services Visiopharm A/S provides quantitative digital pathology solutions for biopharmaceutical companies, contract research organizations, academic medical centers, research institutes and hospitals. Its offers solutions such as BIOTOPIX, ONCOTOPIX, and STEREOTOPIX. The company was founded by Michael Grunkin and Johan Doré Hansen in 2001 and is headquartered in Horsholm, Denmark. | Packaged Software | Director/Board Member | |
ACADIA Pharmaceuticals A/S
 ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Part of ACADIA Pharmaceuticals, Inc., ACADIA Pharmaceuticals A/S utilizes technology to fuel drug discovery and clinical development. The private company is based in Glostrup, Denmark. The Danish company was founded by Peter Høngaard Andersen. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| VIROGATES A/S | Medical Specialties | Director/Board Member | |
| ASCENDANT RESOURCES INC. | Other Metals/Minerals | Chief Executive Officer Chief Operating Officer | |
CytoTrack ApS
 CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology CytoTrack ApS engages in the provision of medical scanners for rare cell detection systems. Its products include CytoTrack CT11 scanner, CytoDisk and CytoCover, and CytoTrack reagent kit. The company was founded by Christian Caspersen, Tom Hede Markussen and Lars Ulrik Nielsen in 2004 and is headquartered in Lyngby, Denmark. | Electronic Equipment/Instruments | Chief Tech/Sci/R&D Officer | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ascendis Pharma GmbH
 Ascendis Pharma GmbH Pharmaceuticals: MajorHealth Technology Ascendis Pharma GmbH engages in research and development related to the administration of bioactive substances by cleavable linkers, as well as related activities. The company is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
| FLUOGUIDE A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ascendis Pharma Endocrinology Division A/S
 Ascendis Pharma Endocrinology Division A/S Pharmaceuticals: MajorHealth Technology Ascendis Pharma Endocrinology Division A/S engages in pharmaceutical preparations. The company was founded on June 29, 2012 and is headquartered in Hellerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CESSATECH A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Genau & More A/S | Director/Board Member | ||
| Ascendis Pharma Bone Diseases A/S | Chief Executive Officer Chairman | ||
| Ascendis Pharma Growth Disorders AS | Chief Executive Officer Chairman | ||
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chairman |
Statistiques
Internationale
| Danemark | 22 |
| Etats-Unis | 19 |
| Royaume-Uni | 3 |
| Suisse | 3 |
| Chine | 3 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 221 |
| Corporate Officer/Principal | 101 |
| Independent Dir/Board Member | 69 |
| Chairman | 63 |
| Chief Executive Officer | 31 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Healy | 50 |
| Heiner Dreismann | 46 |
| Jonathan Silverstein | 42 |
| Albert Cha | 30 |
| Lars Holtug | 26 |
| Rafaèle Elisabeth Tordjman | 23 |
| Michael Wolff Jensen | 23 |
| Martin Olin | 22 |
| Mark Brennan | 21 |
| William Fairey | 15 |
| Jonathan Leff | 14 |
| Edwin de Graaf | 14 |
| Birgitte Volck | 13 |
| Lisa Bright | 13 |
| Jan Mikkelsen | 13 |
- Bourse
- Insiders
- Peter Rasmussen
- Connexions Sociétés
